domingo, 6 de mayo de 2018

Reimbursement landscape for molecular testing in non-small cell lung cancer (NSCLC). - PubMed - NCBI

Reimbursement landscape for molecular testing in non-small cell lung cancer (NSCLC). - PubMed - NCBI



 2018 Feb;24(2 Spec No.):SP37-SP42.

Reimbursement landscape for molecular testing in non-small cell lung cancer (NSCLC).

Nellesen D, Dea K, Guerin A, Culver KW, Mutebi A, Dalal A.

PMID:
 
29689141
Free full text
Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)